Clinical Trial Update: Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC [Phase 2]

View source ↗

Summary

Phase II trial comparing FOLFOXIGIL and FOLFOXIRI as first-line therapy for metastatic colorectal cancer has been withdrawn. The study status indicates the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOXIGIL
• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN